Best HLA-typing hematologist-oncologists in Turkey: TOP 28 doctors

Prof. Baris Akin is a highly esteemed professor of surgery based in Istanbul, Turkey, with a specialization in kidney and pancreas transplantation. He received the 'Young Investigator Award' at the American Transplant Meeting in 2004 and has successfully conducted over 1200 kidney transplantations in Turkey. Prof. Akin has developed a new donor nephrectomy surgical technique and is certified as a transplant surgeon by the American Society of Transplant Surgeons.

Prof. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.

Prof. Dr. Serdar Bedii Omay graduated from Hacettepe Medical School in 1985 and later specialized in Internal Medicine and Hematology. He has published 65 scientific articles, 112 meeting papers, and 34 conference presentations in the field of Hematology and Bone Marrow Transplantation. He has also worked as a Hematology Specialist and Molecular Hematology Doctor at Japan Mie Medical Faculty in 1995.

Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.

Education and Expertise

1996-2002 – Ankara University Faculty of Medicine – Medical Education

2003-2009 – Baskent University Faculty of Medicine, Department of General Surgery – Specialization Training

Experience

2009-2011 – Yüksekova State Hospital, Compulsory Service

2011-2012 – Van/Özalp, 6th Border Regiment, Military Service

2012-2018 – Baskent University Istanbul Health Application and Research Center Hospital

2018-2022 – Istanbul Aydın University Istanbul Health Practice and Research Center Hospital

Courses and Certificates

Selim Anorectal Diseases Course, Turkish Colon and Rectal Surgery Association, Istanbul, 17.12.2016 (National)

Training Program on Istanbul Protocol, Practitioner Training, Van, 06.11.2009-07.11.2009 (International)

Burn Course, Ankara Surgery Association, Başkent University, Ankara, 11.04.2009 (National)

Gazi Hernia Days, Hernia Course, Gazi University, Ankara, 18.10.2008-19.10.2008 (National)

Innovations in Breast Cancer Diagnosis and Treatment, Ankara Breast Diseases Association, Ankara, 22.03.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on " Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Cell Research Board. He is the founding president of the FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Cell Transplantation (, )

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

BRIEF SUMMARYOF WORK EXPERIENCE 

Including those I had transplanted during my fellowship at RUSH University in Chicago (n=86), I have performed a total of 705 liver transplants (%94 adult) both from living (%75) and cadaveric (%25) donors. And, additionally 340 kidney transplants which were mostly from living donors, too. Of these, 12 were combined liver and kidney transplantations either from cadaveric or living donors. Currently, I am the Director of Organ Transplant Program at GUVEN Hospital in Ankara. As of March 2018, here in GUVEN Hospital, we have performed 145 liver transplants (118 from living donors) with 1, 3 and 5 years patient survival of 91.2%, 86%and 83%, consecutively(ELTR data analysis). Since 1997, besides organ transplantation, I have also been operating on complicated hepato-pancreato-biliary patients

Current Workplaces: 

1 Izmir-Buca SSK Hospital 

2 Ankara Training and Research Hospital 

3 Başkent University 

4 Uludağ University 

5 Acıbadem University 

6 Florence Nightingale Hospital (current workplace) 

Education:

1989 Uludağ University Faculty of Medicine 

1984 Ankara Training and Research Hospital General Surgery Residency Training

International Articles: 

1. Uslu A. Bozkurt Y, Koç O, EmiroğluR. Çorumlu B. “Preoperative risk factors in patients with biliary obstruction”, Proc. 2 nd European Congress of Surgery. P179, Brussels,1992. 2. Emiroğlu R. Karakayah H, Haberal M. “Does the renal arterial anastomosis place affect the renal transplant patient outcome”, Proc. 25 th Annual Meeting of the American Society of Transplant Surgeons. P625,Chicago,1999 3. Karakayalı H, Moray G, Emiroğlu R. Akkoç R Köseoğlu F, Bilgin N, Haberal M “The results of interspousal kidney transplantation”, Proc.25 th Annual Meeting of the American Society of Transplant Surgeons. P625, Chicago, 1999 4.Emiroğlu R. Karakayalı H. Sevmiş Ş, Turan M. Bilgin N. Haberal M “Clinical identifıcation oftransplant antigens”, Proc. 36 th Congress of the ERA¬EDTA. P290, 1999. 5. Güz G, Emiroğlu R. Karakayalı H, Özdemir FN. Boy vat F. Haberal M. “An alternative method for native nefrectomy in patients with uncontrolled hypertension and/or proteinüria before transplantation”, Proc.36 th Congress of the ERA¬EDTA.P316, 1999 Prof. Remzi Emiroğlu, M.D. 6.Emiroğlu R. Köseoğlu F, Karakayalı H, Bilgin N. Haberal M. “Burn induced immunosuppression and ıt’s effects on graft survival, infection rates and apoptosis rates of “T” lymphocytes in rat model” Proc.Congress of Middle East and Fire Disaster Society, P52, Ankara, 2000. 7. Haberal M. Emiroğlu R.Mahmutoğlu M. Karakayalı H. Turan M, Erdal R. “Alport ‘s syndrome and renal transplantation” Proc.VII th Congress of Middle East Society for organ transplantation. P124, Beirut, 2000. 8. Gençoğlu EA, Aktaş A, Karakayalı H, Emiroğlu R. Niron EA, Haberal M. “Scintigraphic evaluation of graft and native liver fımction after heterotopic liver transplantation”, Proc. 7 th International Congress of the Middle East Society for Organ Transplantation. P141, Beirut, 2000 9. Haberal M, Karakayalı H, Emiroğlu R. Boyacıoğlu S, Arslan G, Bilgin N. “Heterotopic liver transplantation in adolescence” Proc. 7 th International Congress of the Middle East Society for Organ Transplantation. P138, Beirut, 2000 10. Haberal M, Emiroğlu R. Karakayalı H, Arslan G. Turan M. Bilgin N. “Living-donor transplants: Part of the answer to organ shortage”, Proc. 7 th International Congress of the Middle East Society for Organ Transplantation. P74, Beirut, 200011.Haberal M, Karakayalı H. Emiroğlu R. Köseoelu F, Akkoç H, Bilgin N. “Liver transplantation in an adolescent with allagille syndrome” Proc. 7 th International Congress of the Middle East Society for Organ Transplantation. P133, Beirut, 2000 

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.

He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as transplantation.

MEDICAL INTERESTS 

Clotting Disorders (Thrombophilia)

Bleeding Disorders

Myeloproliferative Diseases

Anemias (Anemia)

Acute and Chronic Leukemias

lymphomas